Ricardo Bolanos-Fernandez

Sevilla, AN, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

First-year treatment response predicts the following 5-year disease course in patients with relapsing-remitting multiple sclerosis.

First-year treatment response predicts the following 5-year disease course in patients with relapsing-remitting multiple sclerosis.

Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

Published: September 04, 2024

Long-term disability trajectories in primary progressive MS patients: A latent class growth analysis.

Long-term disability trajectories in primary progressive MS patients: A latent class growth analysis.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: April 07, 2017

Prognostic indicators in pediatric clinically isolated syndrome.

Prognostic indicators in pediatric clinically isolated syndrome.

Journal: Annals of neurology

Published: July 02, 2016

Higher latitude is significantly associated with an earlier age of disease onset in multiple sclerosis.

Higher latitude is significantly associated with an earlier age of disease onset in multiple sclerosis.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: May 17, 2016

Multiple sclerosis in Latin America: A different disease course severity? A collaborative study from the MSBase Registry.

Multiple sclerosis in Latin America: A different disease course severity? A collaborative study from the MSBase Registry.

Journal: Multiple sclerosis journal - experimental, translational and clinical

Published: June 05, 2015

Comparison of switch to fingolimod or interferon beta/glatiramer acetate in active multiple sclerosis.

Comparison of switch to fingolimod or interferon beta/glatiramer acetate in active multiple sclerosis.

Journal: JAMA neurology

Published: February 10, 2015

Defining reliable disability outcomes in multiple sclerosis.

Defining reliable disability outcomes in multiple sclerosis.

Journal: Brain : a journal of neurology

Published: February 04, 2015

The effect of oral immunomodulatory therapy on treatment uptake and persistence in multiple sclerosis.

The effect of oral immunomodulatory therapy on treatment uptake and persistence in multiple sclerosis.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: December 03, 2014

Predictors of disability worsening in clinically isolated syndrome.

Predictors of disability worsening in clinically isolated syndrome.

Journal: Annals of clinical and translational neurology

Published: October 13, 2014

Male Sex Is Independently Associated with Faster Disability Accumulation in Relapse-Onset MS but Not in Primary Progressive MS.

Male Sex Is Independently Associated with Faster Disability Accumulation in Relapse-Onset MS but Not in Primary Progressive MS.

Journal: PloS one

Published: August 26, 2014

Lipid-specific immunoglobulin M bands in cerebrospinal fluid are associated with a reduced risk of developing progressive multifocal leukoencephalopathy during treatment with natalizumab.

Lipid-specific immunoglobulin M bands in cerebrospinal fluid are associated with a reduced risk of developing progressive multifocal leukoencephalopathy during treatment with natalizumab.

Journal: Annals of neurology

Published: August 26, 2014

BREMSO: a simple score to predict early the natural course of multiple sclerosis.

BREMSO: a simple score to predict early the natural course of multiple sclerosis.

Journal: European journal of neurology

Published: July 30, 2014

Showing 1-12 of 20

Last Updated: 09/26/2026